Back to Search
Start Over
Recurrent ETV6::SYK rearrangement in myeloid malignancies confers partial susceptibility to MEK inhibition.
- Source :
-
British journal of haematology [Br J Haematol] 2024 Jul; Vol. 205 (1), pp. 382-386. Date of Electronic Publication: 2024 May 19. - Publication Year :
- 2024
- Subjects :
- Humans
Oncogene Proteins, Fusion genetics
Protein Kinase Inhibitors therapeutic use
Protein Kinase Inhibitors pharmacology
Gene Rearrangement
Male
Female
Middle Aged
Myeloproliferative Disorders genetics
Myeloproliferative Disorders drug therapy
ETS Translocation Variant 6 Protein
Syk Kinase antagonists & inhibitors
Syk Kinase genetics
Repressor Proteins genetics
Proto-Oncogene Proteins c-ets genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1365-2141
- Volume :
- 205
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- British journal of haematology
- Publication Type :
- Report
- Accession number :
- 38763512
- Full Text :
- https://doi.org/10.1111/bjh.19549